Share Price | SBC Medical Group Holdings, Inc. Stock Analysis & Recommendation

Q: Is SBC Medical Group Holdings, Inc. overvalued or undervalued?

As of 13 August 2025, the valuation grade for SBC Medical Group Holdings, Inc. moved from fair to attractive, indicating a positive shift in its perceived value. The company appears undervalued based on its current metrics, with a P/E ratio of 11.684, an EV to EBITDA ratio of 4.9677, and a price to book value that suggests a favorable comparison to its peers. In comparison to its industry, SBC Medical Group Holdings, Inc. is positioned favorably against competitors such as the average industry P/E, which typically reflects higher valuations. Notably, while the company has experienced a year-to-date return of -16.37%, it has outperformed the S&P 500 over the past week and month, with returns of 3.56% and 9.67%, respectively, suggesting a potential rebound in investor sentiment.

Q: Is SBC Medical Group Holdings, Inc. technically bullish or bearish?

As of 1 October 2023, the technical trend for SBC Medical Group Holdings, Inc. is mixed, with a mildly bullish stance on the weekly MACD and KST, while the monthly indicators show bearish signals. The Bollinger Bands are bullish weekly but mildly bearish monthly, and the daily moving averages indicate a mildly bearish trend. Overall, the stock is currently in a bearish to neutral position, with strength primarily derived from the weekly MACD and KST.In terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 3.56% and 9.67% respectively, compared to the S&P 500's returns of 1.05% and 2.33%. However, the year-to-date and one-year returns are significantly negative at -16.37% and -39.3%, underperforming the S&P 500's positive returns of 12.22% and 17.14%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

55.75 k

Shareholding (Sep 2025)

FII

0.39%

Held by 10 FIIs

DII

99.11%

Held by 1 DIIs

Promoter

0.00%

Is SBC Medical Group Holdings, Inc. overvalued or undervalued?

20-Sep-2025

As of August 13, 2025, SBC Medical Group Holdings, Inc. has shifted from a fair to an attractive valuation grade, appearing undervalued with a P/E ratio of 11.684 and favorable comparisons to industry peers, despite a year-to-date return of -16.37%, while recently outperforming the S&P 500 over the past week and month.

View full answer

Is SBC Medical Group Holdings, Inc. technically bullish or bearish?

20-Sep-2025

As of October 1, 2023, SBC Medical Group Holdings, Inc. shows a mixed technical trend with a mildly bullish weekly outlook but bearish monthly indicators, having outperformed the S&P 500 in the short term while significantly underperforming year-to-date and over the past year.

View full answer

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Negative results in Sep 25

INTEREST(HY) At USD 0.1 MM has Grown at 662.5%
OPERATING CASH FLOW(Y) Lowest at USD -13.87 MM
NET PROFIT(HY) At USD 15.24 MM has Grown at -28.97%

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

USD 364 Million (Micro Cap)

P/E

7.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.41

Return on Equity

-999,999.00%

Price to Book

1.47

Revenue and Profits:

Net Sales:

43 Million

(Quarterly Results - Sep 2025)

Net Profit:

13 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-17.12%

6 Months

-21.94%

1 Year

16.72%

2 Years

-70.15%

3 Years

-65.11%

4 Years

0.0%

5 Years

0.0%

SBC Medical Group Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

1,239.63%

EBIT Growth (5y)

637.57%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

2.61%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.47

EV to EBIT

3.54

EV to EBITDA

3.40

EV to Capital Employed

1.79

EV to Sales

1.47

PEG Ratio

Dividend Yield

ROCE (Latest)

50.62%

ROE (Latest)

21.70%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 9 Schemes (0.5%)

Foreign Institutions

Held by 10 Foreign Institutions (0.39%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 0.00% vs -8.25% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 433.33% vs -88.84% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "43.40",
          "val2": "43.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.60",
          "val2": "15.20",
          "chgp": "9.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.80",
          "val2": "2.40",
          "chgp": "433.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "366.30%",
          "val2": "335.70%",
          "chgp": "3.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.15% vs 0.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.98% vs 6,333.33% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "205.40",
          "val2": "193.50",
          "chgp": "6.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "89.20",
          "val2": "83.30",
          "chgp": "7.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-18.20",
          "val2": "-0.60",
          "chgp": "-2,933.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "46.70",
          "val2": "38.60",
          "chgp": "20.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "415.60%",
          "val2": "367.20%",
          "chgp": "4.84%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]